Gilde Healthcare Holding B.V. 4
4 · LAVA Therapeutics NV · Filed Oct 15, 2025
Insider Transaction Report
Form 4
Transactions
- Sale
Common Shares
2025-10-13$1.54/sh−47,686$73,436→ 5,246,492 total - Sale
Common Shares
2025-10-14$1.51/sh−227,341$343,285→ 5,019,151 total - Sale
Common Shares
2015-10-15$1.51/sh−200,000$302,000→ 4,819,151 total
Footnotes (4)
- [F1]This figure is the weighted average sales price of multiple trades ranging from $1.53 to $1.55 per share. The Reporting Person undertakes to provide the Staff of the Securities and Exchange Commission, LAVA Therapeutics NV or any security holder of LAVA Therapeutics NV full information about the number of shares sold at each separate price upon request.
- [F2]The shares are held directly by Cooperatieve Gilde Healthcare IV U.A. ("Gilde Healthcare"). Gilde Healthcare IV Management BV ("GHCIVM") manages and advises Gilde Healthcare and is owned by Gilde Healthcare Holding BV ("GHH"). Each of GHCIVM and GHH disclaims beneficial ownership of the shares held by Gilde Healthcare, except to the extent of its respective pecuniary interests therein.
- [F3]This figure is the weighted average sales price of multiple trades ranging from $1.50 to $1.55 per share. The Reporting Person undertakes to provide the Staff of the Securities and Exchange Commission, LAVA Therapeutics NV or any security holder of LAVA Therapeutics NV full information about the number of shares sold at each separate price upon request.
- [F4]This figure is the weighted average sales price of multiple trades ranging from $1.49 to $1.54 per share. The Reporting Person undertakes to provide the Staff of the Securities and Exchange Commission, LAVA Therapeutics NV or any security holder of LAVA Therapeutics NV full information about the number of shares sold at each separate price upon request.